Ebos GroupASX:EBO +0.30%77 PB Ratio is 1.24 as of Jun. 26, 2026, which is 54% below its 10-year median of 2.70. GuruFocus rates ASX:EBO with a GF Score™ of 77/100 and a GF Value™ of A$31.49 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 112 Medical Distribution companies, Ebos Group ranks worse than 58.04% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Ebos Group's share price is A$16.76. Ebos Group's Book Value per Share for the quarter that ended in Dec. 2025 was A$13.54. Hence, Ebos Group's PB Ratio of today is 1.24.
Good Sign:
Ebos Group Ltd stock PB Ratio (=1.32) is close to 10-year low of 1.32.
The historical rank and industry rank for Ebos Group's PB Ratio or its related term are showing as below:
ASX:EBO'
s PB Ratio Range Over the Past 10 Years
Min: 1.28 Med: 2.7 Max: 4.68
Current: 1.31
During the past 13 years, Ebos Group's highest PB Ratio was 4.68. The lowest was 1.28. And the median was 2.70.
ASX:EBO's PB Ratio is ranked worse than 58.04% of 112
companies
in the Medical Distribution industry
Industry Median: 1.03
vs ASX:EBO: 1.31
During the past 12 months, Ebos Group's average Book Value Per Share Growth Rate was 10.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 3.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 11.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 8.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Ebos Group was 26.10% per year. The lowest was -8.20% per year. And the median was 12.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Ebos Group PB Ratio Related Terms
Ebos Group PB Ratio Historical Data
* Premium members only.
The historical data trend for Ebos Group's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Ebos Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Ebos Group's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Ebos Group's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Ebos Group (ASX:EBO) has a PB Ratio of 1.24 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Ebos Group and its competitors. This is 54% below median its historical median of 2.70. Over the past decade, Ebos Group's PB Ratio has ranged from 1.28 to 4.68. According to the industry distribution chart, Ebos Group ranks #65 out of 112 companies in the Medical Distribution industry, placing it in the top 58%.
Is Ebos Group's PB Ratio too high?
Ebos Group's current PB Ratio of 1.24 is 54% below median its 10-year median of 2.70. Over the past 10 years, this metric has ranged from a low of 1.28 to a high of 4.68. The Medical Distribution industry median PB Ratio is 1.03. Ebos Group's value of 1.24 is 20.4% above this industry median. Based on the distribution chart, Ebos Group ranks #65 out of 112 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #65 out of 112 companies for PB Ratio. This places Ebos Group in the lower half of its industry. The industry median PB Ratio is 1.03. Ebos Group's value of 1.24 is 20.4% above this benchmark. Historically, Ebos Group's own PB Ratio has ranged from 1.28 to 4.68 over the past decade. While the company's 10-year median is 2.70 vs. the industry median of 1.03, Ebos Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.03, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ebos Group's current PB Ratio of 1.24 is 20.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Ebos Group and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current PB Ratio is 1.24, which is 54% below median its own 10-year median of 2.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$31.49, compared to a current price of A$16.76 — trading 46.8% below its estimated fair value. The current PB Ratio is 1.24, which is 54% below median its 10-year median of 2.70 and 20.4% above the Medical Distribution industry median of 1.03. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current PB Ratio is 1.24 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (ASX:EBO) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of A$16.76 is trading 46.8% below its estimated GF Value™ of A$31.49.
GuruFocus considers Ebos Group to be Significantly Undervalued.
Key valuation signals for ASX:EBO:
PB Ratio: 1.24 (54% below median its 10-year median of 2.70)
GF Value™: A$31.49 vs. price of A$16.76 (46.8% below fair value)
Industry Position: 20.4% above the Medical Distribution median (#65 of 112)
No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score
Get the complete analysis for ASX:EBO
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EBO has been successfully added to your 
